Shingles
Showing 26 - 50 of 301
Herpes Zoster, Recombinant Zoster Vaccine, Systemic Lupus Erythematosus Trial in Shanghai (Recombinant zoster vaccine, Placebo)
Recruiting
- Herpes Zoster
- +2 more
- Recombinant zoster vaccine
- Placebo
-
Shanghai, Shanghai, ChinaShuang Ye, MD
Sep 27, 2021
Herpes Zoster, HIV Trial in United States (ZOSTAVAX, Placebo)
Completed
- Herpes Zoster
- HIV Infections
- ZOSTAVAX
- Placebo
-
Birmingham, Alabama
- +42 more
Nov 2, 2021
Rheumatic Diseases Trial in Portland (Hepatitis A vaccine, Diphtheria, pertussis, and tetanus booster vaccine)
Recruiting
- Rheumatic Diseases
- Hepatitis A vaccine
- Diphtheria, pertussis, and tetanus booster vaccine
-
Portland, OregonOregon Health & Science University
Sep 14, 2022
Influenza, Herpes Zoster Trial in Nijmegen (Herpes zoster vaccination (Shingrix, GSK), Influenza Vaccine (Fluarix Tetra Northern
Active, not recruiting
- Influenza
- Herpes Zoster
- Herpes zoster vaccination (Shingrix, GSK)
- +2 more
-
Nijmegen, Gelderland, NetherlandsRadboud University
May 19, 2022
Healthy Trial (Quantity of vaccination recommendations, Quality of vaccination recommendations, Control)
Not yet recruiting
- Healthy
- Quantity of vaccination recommendations
- +2 more
- (no location specified)
Jul 14, 2023
Kidney Transplant Recipient Response to Shingrix Vaccine Trial (Shingrix)
Not yet recruiting
- Kidney Transplant Recipient Response to Shingrix Vaccine
- Shingrix
- (no location specified)
Mar 17, 2022
Chronic Wounds Trial in Harbin (HA35(L20200708MP07707, Ministry of Health, Mongolia)was freshly manufactured by mixing
Completed
- Chronic Wounds
- HA35(L20200708MP07707, Ministry of Health, Mongolia)was freshly manufactured by mixing hyaluronidase PH20 injectable solution (H31022111) and high-molecular-weight HA injectable solution (H20174089)
-
Harbin, Heilongjiang, ChinaFar East Hospital
Mar 1, 2023
Herpes Zoster Trial in India (HZ/su, Placebo)
Active, not recruiting
- Herpes Zoster
- HZ/su
- Placebo
-
Visakhapatnam, Andhra Pradesh, India
- +8 more
Jan 6, 2023
Herpes Virus Infections in Kidney Transplant Patients
Recruiting
- Kidney Transplant; Complications
- +2 more
-
Aarhus, Denmark
- +4 more
Jan 30, 2023
Herpes Zoster Ophthalmicus Trial in Canada, United States (Masked Placebo, Masked Oral Valacyclovir)
Active, not recruiting
- Herpes Zoster Ophthalmicus
- Masked Placebo
- Masked Oral Valacyclovir
-
Birmingham, Alabama
- +77 more
Jan 17, 2023
Shear Wave Elastography Trial
Not yet recruiting
- Shear Wave Elastography
- (no location specified)
Jun 24, 2023
Primary Systemic Amyloidosis, Light Chain Deposition Disease Trial in United States (drug, genetic, other, procedure)
Active, not recruiting
- Primary Systemic Amyloidosis
- Light Chain Deposition Disease
- bortezomib
- +6 more
-
Denver, Colorado
- +6 more
Aug 24, 2022
Herpes Zoster Disease Trial in Columbus (An informational packet regarding shingles and the HZV was sent to patients identified
Completed
- Herpes Zoster Disease
- An informational packet regarding shingles and the HZV was sent to patients identified by the EMR
-
Columbus, OhioThe Ohio State University Martha Morehouse General Internal Medi
Aug 27, 2018
Ulcerative Colitis Acute Trial in Ann Arbor (Cyclosporine Injection (IV), Cyclosporine Oral Product, Upadacitinib Extended
Not yet recruiting
- Ulcerative Colitis Acute
- Cyclosporine Injection (IV)
- +4 more
-
Ann Arbor, MichiganUniversity of Michigan
May 6, 2023
Vaccine-Preventable Diseases, Herpes Zoster Trial in Zhenjiang (Recombinant Herpes Zoster Vaccine, Recombinant Herpes Zoster
Recruiting
- Vaccine-Preventable Diseases
- Herpes Zoster
- Recombinant Herpes Zoster Vaccine
- Recombinant Herpes Zoster Vaccine Placebo
-
Zhenjiang, Jiangsu, ChinaJiangsu Province Center for Disease Control and Prevention (Chin
Oct 12, 2023
Healthy Trial in Halifax (Meningococcal B, High-Dose TIV, Tdap (tetanus-diphtheria-acellular pertussis))
Completed
- Healthy
- Meningococcal B
- +5 more
-
Halifax, Nova Scotia, CanadaIWK Health Centre
Mar 10, 2022
Herpes Zoster, Varicella Zoster Trial in Kansas City (CRV 101, Placebo)
Completed
- Herpes Zoster
- Varicella Zoster
- CRV 101
- Placebo
-
Kansas City, MissouriThe Center for Pharmaceutical Research
Feb 10, 2021
Herpes Zoster Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (Shingrix)
Not yet recruiting
- Herpes Zoster
- Shingrix
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Mild Cognitive Impairment, Dementia, Mild Trial in United States (dietary supplement, combination product, behavioral)
Not yet recruiting
- Mild Cognitive Impairment
- Dementia, Mild
- Precision Medicine Approach
- +3 more
-
Folsom, California
- +5 more
May 30, 2023
Behçet Disease Trial in Paris (Subcutaneous Ustekinumab)
Completed
- Behçet Disease
- Subcutaneous Ustekinumab
-
Paris, FranceHôpital Cochin, Department of Internal Medicine, National Refere
Nov 19, 2021
Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma Trial in Canada, United States (drug, procedure,
Active, not recruiting
- Stage I Multiple Myeloma
- +2 more
- dexamethasone
- +4 more
-
Chicago, Illinois
- +4 more
Sep 3, 2022
Rheumatoid Arthritis, Psoriatic Arthritis, Spondylarthritis Trial in Birmingham, Omaha (Upadacitinib, Abatacept, Secukinumab)
Recruiting
- Rheumatoid Arthritis
- +2 more
- Upadacitinib
- +7 more
-
Birmingham, Alabama
- +7 more
Sep 19, 2022
Breast Tumors Trial in Saint Louis (Doxorubicin, Trastuzumab, Cyclophosphamide)
Terminated
- Breast Neoplasms
- Doxorubicin
- +7 more
-
Saint Louis, MissouriWashington University School of Medicine
Oct 31, 2022
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial run by the NHLBI (Ibrutinib, Fludarabine)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Mar 1, 2022